An established tolerability profile

Safety and tolerability supported by 23 years of clinical experience1

Most common* adverse events associated with Avonex compared to placebo2

Adapted from Jacobs et al. 1996.


* Events reported by >10% of total population and at least 5% higher in treatment group than placebo group.
† Fisher’s exact test.

DMT: Disease Modifying Therapy; FLS: Flu-like Symptoms; ISR: Injection Site Reaction.

Biogen-36608. Date of preparation: January 2020